Last updated on August 2018

PROCLAIM-CX-2009: A Trial to Find Safe and Active Doses of an Investigational Drug CX-2009 for Patients With Selected Solid Tumors


Brief description of study

The purpose of this first-in-human study of CX-2009 is to characterize the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD) and antitumor activity of CX-2009 in adult subjects with metastatic or locally advanced unresectable solid tumors. PROCLAIM: PRObody CLinical Assessment In Man CX-2009 clinical trial 001

PROBODY is a trademark of CytomX Therapeutics, Inc

Clinical Study Identifier: NCT03149549

Contact Investigators or Research Sites near you

Start Over

Lori Carman

Yale University School of Medicine - Yale Cancer Center
New Haven, CT United States
  Connect »

Lori Carman

University of Chicago
Chicago, IL United States
  Connect »

Lori Carman

Indiana University Health Melvin and Bren Simon Cancer Center
Indianapolis, IN United States
  Connect »

Lori Carman

Memorial Sloan Kettering Cancer Center
New York, NY United States
  Connect »

Lori Carman

University Hospitals Cleveland Medical Center
Cleveland, OH United States
  Connect »

Lori Carman

Providence Portland Medical Center
Portland, OR United States
  Connect »

Lori Carman

The Sarah Cannon Research Institute
Nashville, TN United States
  Connect »

Lori Carman

Mary Crowley Medical Research Center
Dallas, TX United States
  Connect »

Lori Carman

Viriginia Cancer Specialists
Fairfax, VA United States
  Connect »

Lori Carman

USC Norris Comprehensive Cancer Center
Los Angeles, CA United States
  Connect »

Lori Carman

Dana-Farber Cancer Institute
Boston, MA United States
  Connect »

Lori Carman

Barbara Ann Karmanos Cancer Institute
Detroit, MI United States
  Connect »

Lori Carman

Roswell Park Cancer Institute
Buffalo, NY United States
  Connect »

Lori Carman

MD Anderson Cancer Center
Houston, TX United States
  Connect »

Lori Carman

Huntsman Cancer Institute
Salt Lake City, UT United States
  Connect »

Lori Carman

Swedish Cancer Institute (SCI)
Seattle, WA United States
  Connect »

Lori Carman

University of Wisconsin-Carbone Cancer Center
Madison, WI United States
  Connect »

Lori Carman

Hospital Clinic Barcelona
Barcelona, Spain
  Connect »

Lori Carman

Centro Integral Oncologico Clara Campal
Madrid, Spain
  Connect »

Lori Carman

University of California, Los Angeles (UCLA) - Medical Center
Santa Monica, CA United States
  Connect »

Lori Carman

Rush University Medical Center
Chicago, IL United States
  Connect »

Lori Carman

New York University (NYU) Clinical Cancer Center
New York, NY United States
  Connect »

Lori Carman

Columbia University College of Physicians & Surgeons, Columbia University
New York, NY United States
  Connect »

Lori Carman

Amsterdam UMC - Locatie VUmc
Amsterdam, Netherlands
  Connect »

Lori Carman

Universitair Medisch Centrum Groningen
Groningen, Netherlands
  Connect »

Lori Carman

Instituto Catalan de Oncologia - Hospital Duran i Reynals
Barcelona, Spain
  Connect »

Lori Carman

Instituto Valenciano de Oncologia
Valencia, Spain
  Connect »

Lori Carman

Sarah Cannon Research Institute UK Limited
London, United Kingdom
  Connect »